HASSAN EMIL E 4
4 · NATIONAL HEALTHCARE CORP · Filed May 1, 2026
Research Summary
AI-generated summary of this filing
NHC Director Emil E. Hassan Exercises Options for 7,500 Shares
What Happened
Emil E. Hassan, a director of National Healthcare Corp (NHC), exercised stock options on 2026-04-30 to acquire 7,500 common shares at an exercise price of $71.64 per share, for a total cash outlay of $537,300. The filing also records the corresponding derivative (the option) being disposed/converted (7,500 units at $0.00), reflecting the option-to-share conversion rather than an open-market sale.
Key Details
- Transaction date: 2026-04-30. Exercise price: $71.64; shares acquired: 7,500; total ≈ $537,300.
- Derivative conversion: 7,500 option units shown as disposed at $0.00 (conversion of the option into shares).
- Shares owned after transaction: not specified in the provided filing details.
- Footnote: Options were granted under the 2020 Omnibus Equity Incentive Plan on May 6, 2021; grant and exercise are exempt from Section 16(b) under Rule 16b-3(d).
- Filing timeliness: Report filed 2026-05-01 for a 2026-04-30 transaction (timely within Form 4 reporting rules).
Context
This was an options exercise (insider acquiring shares), not an immediate sale on the open market. The record shows the option was converted into shares; there is no indication the shares were sold immediately (no sale reported). Exemptions cited mean the transaction is not subject to short-swing profit recovery under Section 16(b).
Insider Transaction Report
- Exercise/Conversion
Shares of Common Stock
[F1]2026-04-30$71.64/sh+7,500$537,300→ 73,095 total - Exercise/Conversion
Option to Purchase Common Stock [2021 Grant]
[F1]2026-04-30−7,500→ 0 totalExercise: $71.64From: 2022-05-06Exp: 2026-05-05→ Common Stock (7,500 underlying)
- 7,500
Option to Purchase Common Stock [2022 Grant]
Exercise: $69.19From: 2023-05-05Exp: 2027-05-04→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2023 Grant]
Exercise: $55.75From: 2024-05-04Exp: 2028-05-03→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2024 Grant]
Exercise: $96.03From: 2025-05-09Exp: 2029-05-08→ Common Stock (7,500 underlying) - 7,500
Option to Purchase Common Stock [2025 Grant]
Exercise: $94.66From: 2026-05-08Exp: 2030-05-07→ Common Stock (7,500 underlying)
Footnotes (1)
- [F1]These stock options were granted pursuant to the 2020 Omnibus Equity Incentive Plan on May 6, 2021. The grant and exercise of these stock options are exempt from Section 16(b) pursuant to Rule 16b-3(d).